PGI3 LEAN AND OBESE PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) / NON-ALCOHOLIC FATTY LIVER DISEASE (NALFD); COMPARISONS OF POPULATIONS AND DISEASE PROGRESSION

To assess differences in characteristics and disease progression in lean (BMI <25) compared to obese (BMI >30) patients with NASH/NAFLD. US EMR data were limited to adults with NASH/NAFLD (ICD10 K76, 75.81) with BMI <25 or ≥30 but without viral hepatitis, advanced liver disease or evidence of alcohol abuse. Baseline date was the first calculable FIB4 between July 2015 - Jun 2017 with >1 year history and >2 years follow-up or death. Definition of...